The WHO-led COVAX Facility announced Friday that it has now secured some 2 billion vaccine doses and distribution of vaccines will begin in the first quarter of 2021 – ensuring that at least some vaccines will begin to reach the 92 low-income countries that are largely dependent on global philanthropy to access sufficient vaccine supplies. […] Continue reading ->
Indian lockdowns, telehealth in California, a “sin tax” on alcohol and cigarettes in the Philippines – three public health advocates reflect on how these and other events have shaped the narrative around non-communicable diseases (NCDs).  The three included Apoorva Gomber, a medical doctor; Gina Agiostratidou, a philanthropic donor; and civil society leader Katie Dain, found […] Continue reading ->
Striking through the politicised warnings and potentially hollow gestures, a new study has found that COVID-19 vaccines could remain out of reach until at least 2022 for nearly one- fifth of the global population – despite months of pleas and appeals to ensure their widespread global distribution. The study, published in The BMJ, is the […] Continue reading ->
WHO’s Director General Dr Tedros Adhanom Ghebreyesus on Friday issued yet another plea to leaders of rich countries to “honor their pledges” to fund COVID-19 vaccines sufficient to immunize the highest risk groups across the world. He spoke a day after South African officials raised the spectre that the world was heading towards a state […] Continue reading ->

Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227
London. The cameras were focused on the face of 90 year-old Margaret Keenan, the first UK citizen to receive the newly approved Pfizer/BioNTech COVID-19 vaccine on Tuesday at University Hospital in the city of Coventry.  After her jab, she passed through a corridor of applauding nurses. Behind her mask was the glint of a smile […] Continue reading ->
Just hours after the UK jabbed its first citizen against the coronavirus, researchers have confirmed that Oxford’s vaccine is safe and effective in the first peer-reviewed publication of a Phase III coronavirus vaccine trial yet.  “The results for me are very compelling,” said AstraZeneca’s executive vice president Mene Pangalos on Wednesday at a press conference. […] Continue reading ->